Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study

Abstract

Mulugeta Russom,1– 3 Daniel YB Jeannetot,2 Sirak Tesfamariam,4 Bruno H Stricker,5 Katia Verhamme2 1Eritrean Pharmacovigilance Centre, National Medicines and Food Administration, Ministry of Health, Asmara, Eritrea; 2Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, the Netherlands; 3European Program for Pharmacovigilance and Pharmacoepidemiology, University of Bordeaux, Bordeaux, France; 4Product Evaluation and Registration Unit, National Medicines and Food Administration, Ministry of Health, Asmara, Eritrea; 5Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the NetherlandsCorrespondence: Mulugeta Russom, Eritrean Pharmacovigilance Centre, National Medicines and Food Administration, Ministry of Health, P.O.Box: 212, Asmara, Eritrea, Tel [phone], Email [email protected]: In Eritrea, a 6-month isoniazid preventive therapy (IPT) was introduced in Eritrea in 2014 to prevent/reduce risk of incident tuberculosis in people living with HIV (PLHIV). The global and local uptake of IPT in newly enrolled PLHIV was reported to be low. Anecdotal reports showed that there was resistance from clinicians against its implementation. This study was therefore conducted to explore the factors that affect implementation of IPT in Eritrea from the perspectives of healthcare professionals.Materials and Methods: An exploratory qualitative study that used a framework content analysis using inductive approach was employed. Data were collected from a sample of HIV care clinic prescribers from regional and national referral hospitals through in-depth interviews. Senior program officers were also interviewed as key informants. A conceptual framework model was developed using a root cause analysis.Results: Overall, five themes and 13 sub-themes emerged from the in-depth interviews with healthcare professionals and key informants. Several multi-level causes/factors related to the healthcare system, HIV control program, healthcare professionals, patients and the product were identified as barriers to the implementation of IPT. Information gap on IPT and fear of isoniazid-induced liver injury were identified as the main reasons for the reluctance in administering IPT. It was observed that healthcare professionals had significant information gap that resulted in rumors and doubts on the benefits and risks of IPT, which ultimately caused reluctance on its implementation. Inadequate planning and operationalization during the introduction of IPT and inadequate laboratory setups were found to be the possible root causes for the aforementioned central problems.Conclusion: The root causes/factors for the limited implementation of IPT in Eritrea were mainly related to the HIV control program and the healthcare system. Adequate planning, operationalization and capacitation of the existing laboratory setups are recommended for a successful implementation of IPT.Keywords: isoniazid preventive therapy, tuberculosis preventive therapy, people living with HIV, implementation, limiting factors, barriers

Keywords

• isoniazid preventive therapy
• tuberculosis preventive therapy
• people living with hiv
• implementation
• limiting factors
• barriers.